Objective:

To investigate the impact of DPP9 deficiency on tumor growth and metastasis in triple-negative breast cancer (TNBC) and its sensitivity to combined irradiation and Olaparib therapy.

Approach:

Key Findings:

• DPP9 deficiency led to increased tumor weight and more lung metastasis compared to controls.
• Irradiation reduced tumor growth initially, but DPP9-deficient tumors grew faster post-irradiation.
• Combined treatment with irradiation and Olaparib significantly reduced tumor growth in DPP9-deficient tumors.

Interpretation:

Remove or rephrase to avoid unsupported conclusions.

Limitations:

• Study conducted in a mouse model, which may not fully replicate human disease.
• Mixed outcomes observed in metastasis formation in DPP9-deficient tumors.

Conclusion:

Revise to eliminate implications about therapeutic targeting.

Attribution Notice

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.